New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
07:36 EDTVSIVitamin Shoppe comps should should show acceleration, says RW Baird
Baird expects Q2 earnings at Vitamin Shoppe to be in-line but believes its comparable sales should show an acceleration and an improved margin performance relative to prior quarters. The firm also believes concerns over increased promotional activity are overblown. Baird likes the stock at current levels and keeps a Buy rating with a $55 price target on the shares.
News For VSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
07:39 EDTVSIVitamin Shoppe Q2 results expected to be soft, says Baird
Baird expects Vitamin Shoppe to report soft Q2 results citing negative comps and significant EBIT margin compression. The firm noted investor sentiment is low heading into the results and that it expects more details on the new CEO's strategic position. Baird reiterated its Outperform rating and $45 price target on Vitamin Shoppe shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use